Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

980 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 980 results

Not applicableNot Yet RecruitingNCT07789938
What this trial is testing

Intraoperative Neurophysiological Monitoring in Brain Tumor Surgery: Prospective Cohort Studies

Who this might be right for
Intraoperative Neurophysiological MonitoringMalignant Brain TumorsMotor Evoked Potential Monitoring+2 more
Odense University Hospital 166
Not applicableLooking for participantsNCT05672043
What this trial is testing

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

Who this might be right for
MedulloblastomaCentral Nervous System Tumor, PediatricEpendymoma+3 more
Beijing Tiantan Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Large-scale testing (Phase 3)WithdrawnNCT00226668
What this trial is testing

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Who this might be right for
Brain EdemaBrain Tumor
Celtic Pharma Development Services 120
Testing effectiveness (Phase 2)Study completedNCT00006268
What this trial is testing

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00003616
What this trial is testing

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT01641068
What this trial is testing

Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms

Who this might be right for
Breast CarcinomaCancer SurvivorCognitive Side Effects of Cancer Therapy+1 more
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT00381797
What this trial is testing

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Who this might be right for
Childhood Cerebral Anaplastic AstrocytomaChildhood OligodendrogliomaChildhood Spinal Cord Neoplasm+3 more
National Cancer Institute (NCI) 97
Not applicableEnded earlyNCT03328858
What this trial is testing

Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor

Who this might be right for
Brain Tumors
Nicklaus Children's Hospital f/k/a Miami Children's Hospital 2
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Looking for participantsNCT05857969
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more
Florida International University 65
Early research (Phase 1)Study completedNCT00068510
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 28
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT02537600
What this trial is testing

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Who this might be right for
Malignant Melanoma
Center Eugene Marquis 43
Very early researchEnded earlyNCT02279992
What this trial is testing

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

Who this might be right for
GliomaBrain NeoplasmsBrain Metastasis
Cedars-Sinai Medical Center 7
Early research (Phase 1)Study completedNCT00730613
What this trial is testing

Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 3
Not applicableEnded earlyNCT04947618
What this trial is testing

Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim

Who this might be right for
Lymphoma, Malignant
Centre Hospitalier Universitaire de Nīmes 136
Next Page